Financial Summary (All financials)
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
Revenues | 3,132.5 | 2,998.1 | 2,622.1 | 3,802.1 | 3,808.7 | 3,705.4 | 3,038.3 | 4,753.8 |
Revenue growth | 4.5% | 14.3% | -31.0% | -0.2% | 2.8% | 22.0% | -36.1% | 2.6% |
Cost of goods sold | 2,142.1 | 1,963.5 | 1,744.0 | 2,492.4 | 2,470.8 | 2,369.0 | 1,791.5 | 3,050.9 |
Gross profit | 990.4 | 1,034.6 | 878.1 | 1,309.7 | 1,337.9 | 1,336.4 | 1,246.8 | 1,702.9 |
Gross margin | 31.6% | 34.5% | 33.5% | 34.4% | 35.1% | 36.1% | 41.0% | 35.8% |
Selling, general and administrative | | | | | | 1,048.9 | | 1,523.8 |
Sales and marketing | 597.6 | 518.5 | 428.8 | 600.5 | 607.2 | | 477.4 | |
Research and development | 26.7 | 29.8 | 29.2 | 43.5 | 44.6 | | 27.0 | |
General and administrative | 371.4 | 389.2 | 360.5 | 354.6 | 335.8 | | 346.0 | |
EBITA | 73.5 | 162.2 | 88.1 | 311.1 | 350.3 | 2,656.5 | 396.4 | 246.3 |
EBITA margin | 2.3% | 5.4% | 3.4% | 8.2% | 9.2% | 71.7% | 13.0% | 5.2% |
Amortization of intangibles | 50.3 | 65.1 | 55.3 | | | | | |
EBIT | 23.2 | 97.1 | 32.8 | 311.1 | 350.3 | 2,656.5 | 396.4 | 246.3 |
EBIT margin | 0.7% | 3.2% | 1.3% | 8.2% | 9.2% | 71.7% | 13.0% | 5.2% |
Pre-tax income | -90.3 | -11.1 | -25.1 | -193.8 | -35.7 | -27.9 | 9.2 | -180.1 |
Income taxes | -13.3 | -26.4 | 27.3 | -7.1 | -462.7 | -11.8 | -58.4 | 39.6 |
Tax rate | 14.7% | 237.8% | | 3.7% | 1296.1% | 42.3% | | |
Earnings from continuing ops | -154.0 | 15.3 | -52.4 | -188.0 | 323.3 | -90.6 | -29.7 | -264.1 |
Earnings from discontinued ops | 149.7 | 174.3 | 150.9 | 682.5 | 445.0 | 289.3 | -101.5 | -292.7 |
Net income | -4.3 | 189.6 | 98.5 | 494.5 | 768.3 | 106.0 | -131.2 | -556.8 |
Net margin | -0.1% | 6.3% | 3.8% | 13.0% | 20.2% | 2.9% | -4.3% | -11.7% |
|
Diluted EPS | ($3.77) | $0.35 | ($1.17) | ($3.71) | $8.74 | ($2.81) | ($0.93) | ($1.33) |
Shares outstanding (diluted) | 40.9 | 43.2 | 44.7 | 50.7 | 37.0 | 32.2 | 32.0 | 198.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|